Lawrenz Hannah Martin
Biotechniques. 2018 Jan 1;64(1):9-10. doi: 10.2144/000114625.
Newly engineered bacterial strains propel an immune-mediated cancer therapy toward clinical applications. Hannah Martin Lawrenz reports on the latest developments.
新改造的细菌菌株推动免疫介导的癌症治疗走向临床应用。汉娜·马丁·劳伦兹报道了最新进展。